Bias plays a big part in human efficiency but sometimes the outcomes can be counterproductive. In this episode of Bridging the Gap, Dr. Greg Hall will look at the latest data regarding bias in healthcare delivery and how some of our biases have the opposite effect we want. We will then look at best practices for correcting for bias in patient encounters.
Because of the increased burden of an array of cancers, African Americans have screening recommendations that are sometimes different from the majority population. Dr. Hall will review the current US cancer demographics as well as recommendations for cancer screening in African Americans and other communities of color. When a cancer diagnosis is discovered, the related discussion needs to be delicately handled in many cases. We will review the attitudes, perceptions, and beliefs regarding a cancer diagnosis in African American patients and best practices for successful outcomes.
Episode 12: Bridging the Gap: Conversations with Dr. Hall
Literature consistently shows lower engagement in advance-care-planning among ethnic and racial minority groups when compared to Whites. A recent study with a nationally representative sample reported that only 18% of ethnic minority participants completed advance directives compared to 34% of White respondents. Studies in hospital settings also found lower rates of discussion about advance-care-planning with a physician during the hospitalization among racial/ethnic minority patients when compared to Whites. Given that engagement in advance-care-planning and end-of-life discussions positively influences the quality of life near its end, a lower engagement in these meaningful discussions among ethnic minorities can lead to inadequate care at the last stage of life, exacerbating earlier health disparities. There are also significant differences in the treatment of pain in African Americans, as well as the perception of pain, and potential for abuse.
With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss how seropositivity levels can vary after vaccination and which patients would make good candidates for monoclonal antibodies (mAbs). You’ll also hear the latest clinical trials data on the efficacy of mAbs.
This lecture will provide a comprehensive overview of contraceptive options for women of child-bearing ages. The significance and impact of prescribing practices on women will be discussed highlighting the importance of reproductive planning in all female patients with childbearing potential. Principles of effective contraceptive counseling will be outlined. Risks, benefits and medical indications for various contraceptive methods will be reviewed. Initiation and management of noncompliance with various contraceptive methods will also be discussed. A practical approach to management of contraceptive side effects will be discussed as well as risk/benefit assessments in choice of most appropriate contraceptive options.
This podcast will provide an update on the medical literature and practice guidelines pertaining to exercise. Participants will deepen their understanding of the physical and mental health benefits of exercise and will examine the evidence for a variety of common approaches to exercise (cardiovascular, strength training, high intensity interval training). Barriers to participation in exercise regimens – both for patients and providers – will be explored.
Doc, Justin Bieber Has Lyme Disease And I Think I Do Too! What To Do When Your Patients Come To You With Somatic Complaints That They Attribute to Microbial Exposure
With the widespread accessibility to information on the Internet, much of which is not necessarily evidence-based, it appears that patients are more frequently consulting with their caregivers about vague somatic complaints that they think are due to exposure to various microbial organisms. Chronic Lyme disease has become a favorite disease due to some well-publicized celebrities announcing that they are suffering from this disorder. Patients also complain from the effects of mold exposure (“Toxic mold”), parasite infestations (delusions of parasitosis or Morgellon disease), among others. Patients can be very insistent, demanding therapies that are not supported by evidence. This presentation will assist practitioners as to how to appropriately diagnose and counsel patients about these various disorders.
Lifestyle management has proven effective for addressing modifiable health risks, but can be challenging for patients to implement and maintain. This session will focus on wellness coaching as an important component of healthy living, both for patients and providers. Participants will learn about the benefits of engaging patients in health and wellness coaching, and will discuss strategies for incorporating this practice into their own patient care setting(s).
Through fifteen quick-hitting cases, this session will review select dermatologic rashes and neoplasms, both benign and malignant, that are commonly encountered by primary care physicians. Clinical descriptions of acne, alopecia areata, atopic dermatitis/eczema, lichen planus, pityriasis rosea, psoriasis, rosacea, seborrheic dermatitis, stasis dermatitis, tinea cruris/corporis/unguium, acrochordon, cherry angioma, seborrheic keratosis, actinic keratosis, basal cell carcinoma, squamous cell carcinoma, and melanoma are provided, followed by suggestions for treatment and management within the scope of primary care. Recommendations as to when to refer patients to Dermatology are noted. Reference atlas, textbook, website, and mobile application recommendations are also provided.
Episode 5: Coffee with Chopra
Join Dr. Sanjiv Chopra in this installment of Coffee with Chopra, as he interviews urologist and author, Dr. Abraham Morgentaler, about topics relevant to Men’s Health including prostate cancer, male sexuality, testosterone replacement therapy, and the concept of “male menopause”.
In recent years, promising evidence has emerged for new pharmacologic treatments for heart failure with reduced ejection fraction (HFrEF); however, gaps in clinician prescribing for the current guideline-directed therapies still exist. Join cardiology experts Ty Gluckman, MD, and Alison Bailey, MD, as they review the current recommendations for guideline-directed medical therapy in HFrEF, discuss strategies for implementing it, and assess the evidence for new and emerging treatments for HFrEF and recently approved agents, including SGLT2 inhibitors, vericiguat, and omecamtiv mecarbil.